| Drug Name: | Carbon tetrachloride (56-23-5) |
|---|---|
| PubChem ID: | 5943 |
| SMILES: | C(Cl)(Cl)(Cl)Cl |
| InchiKey: | VZGDMQKNWNREIO-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 153.823 |
| LogP | : | 2.5529 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 0 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 0 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Hepatic Injury | Alpha-2A adrenergic receptor (P08913) | Potentiation of carbon tetrachloride hepatotoxicity appears to be mediated by alpha(2)-adrenoceptor stimulation@creating the potential for increased susceptibility to hepatic injury [ ADR Type 2 ] | Adrenergic modulation of hepatotoxicity |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|